Dr. Di Stasi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1802 6th Ave S Np255
Birmingham, AL 35233Phone+1 205-934-1908
Summary
- I received an M.D. degree from the University of Modena in Italy, and peformed internal medicine and medical oncology training at the university of Milan, in Italy, focusing on the management of hematologic malignancies and hematopoietic stem cell transplantation. Afterwards I joined the Center for Cell and Gene Therapy (Baylor College of Medicine, Houston, TX) for post-doctoral studies, and the University of Texas MD Anderson Cancer Center for Bone Marrow Transplantation fellowship and clinical research. Currently I am physician-scientist at UAB, Birmingham AL, in the BMT& Cell Therapy Program.
Education & Training
- Baylor College of MedicinePost-Doctoral Fellowship, 2005 - 2009
- Istituto Nazionale TumoriFellowship, Cum laude, 2000 - 2004
- University of Modena Faculty of MedicineClass of 2000, MD, Cum laude
Certifications & Licensure![](https://directory.doximity.com/assets/icons/icon-help-e9f0b148a1e6d1f037dde9f26f025c36bd7c99fd4fe31fd76792996fa2aa5e66.svg)
- AL State Medical License 2014 - 2025
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 26 citationsAxatilimab for Chronic Graft-Versus-Host Disease After Failure of at Least Two Prior Systemic Therapies: Results of a Phase I/II Study.Carrie L Kitko, Mukta Arora, Zachariah DeFilipp, Mohammad Abu Zaid, Antonio Di Stasi
Journal of Clinical Oncology. 2023-04-01 - 6 citationsDismal survival outcomes of patients with acute myeloid leukemia after failure of venetoclax with hypomethylating agents.Carl Zainaldin, Sankalp Arora, Srilakshmi Bathini, Udita Gupta, Vishruti Pandya
Leukemia & Lymphoma. 2022-12-01 - Phase II study of myeloablative allogeneic hematopoietic stem cell transplantation for acute lymphoblastic leukemia in adults using fludarabine and total body irradiat...Omer Jamy, Sankalp Arora, Ruby Meredith, Donna Salzman, Antonio Di Stasi
Bone Marrow Transplantation. 2022-10-01
Books/Book Chapters
Professional Memberships
- Member
Other Languages
- Italian
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: